NEW YORK, Jan. 4, 2021 /PRNewswire/ --
If you own shares in any of the companies listed above and would like to discuss our investigations or have any questions concerning this notice or your rights or interests, please contact:
Joshua Rubin, Esq.
WeissLaw LLP
1500 Broadway, 16th Floor
New York, NY 10036
(212) 682-3025
(888) 593-4771
[email protected]
ZAGG Inc.
WeissLaw LLP is investigating possible breaches of fiduciary duty and other violations of law by the board of directors of ZAGG Inc. in connection with the proposed acquisition of the company by a group led by Evercel, Inc. Under the terms of the acquisition agreement, the company's shareholders will only receive $4.20 per share in cash and a contingent amount of up to $0.25 for each share of ZAGG common stock that they hold. If you own ZAGG shares and wish to discuss this investigation or your rights, please call us at one of the numbers listed above or visit our website: https://www.weisslawllp.com/zagg/
Pluralsight, Inc.
WeissLaw LLP is investigating possible breaches of fiduciary duty and other violations of law by the board of directors of Pluralsight, Inc. in connection with the proposed acquisition of the company by Vista Equity Partners. Under the terms of the acquisition agreement, PS shareholders will receive $20.26 per share in cash for each share of PS common stock that they hold. If you own PS shares and wish to discuss this investigation or your rights, please call us at one of the numbers listed above or visit our website: https://weisslawllp.com/news/ps/
TCF Financial Corporation
WeissLaw LLP is investigating possible breaches of fiduciary duty and other violations of law by the board of directors of TCF Financial Corporation in connection with the proposed stock-for-stock merger of the company with Huntington Bancshares Incorporated ("Huntington"). Under the terms of the merger agreement, TCF shareholders will receive 3.0028 shares of Huntington common stock for each share of TCF that they hold, representing implied per-share merger consideration of $37.72 based upon Huntington's January 4, 2021 closing price of $12.46. If you own TCF shares and wish to discuss this investigation or your rights, please call us at one of the numbers listed above or visit our website: https://www.weisslawllp.com/tcf/
Seneca Biopharma, Inc.
WeissLaw LLP is investigating possible breaches of fiduciary duty and other violations of law by the board of directors of Seneca Biopharma, Inc. in connection with the company's proposed merger with Leading BioSciences, Inc. ("LBS"). Under the terms of the agreement, LBS shareholders will receive shares of SNCA, resulting in LBS stockholders owning a majority of the combined company, with SNCA shareholders owning just 26.2% of the surviving combined entity. If you own SNCA shares and wish to discuss this investigation or your rights, please call us at one of the numbers listed above or visit our website: https://www.weisslawllp.com/snca/
SOURCE WeissLaw LLP
![](https://rt.prnewswire.com/rt.gif?NewsItemId=DC37214&Transmission_Id=202101042130PR_NEWS_USPR_____DC37214&DateId=20210104)
Share this article